Category Medicine and Healthcare
Press Release
Dr. Shervin Naderi Surpasses 10,000 Non-Surgical Rhinoplasty Procedures, Setting the Standard for Safe and Expert Nose Contouring
With more than 10,000 procedures performed, Dr. Naderi discusses the technical demands and aesthetic advantages of non-surgical rhinoplasty using dermal fillers. Read More
Press Release
DEA Bungles Marijuana Policy- Blocks FDA Studies While CCP Illegal Marijuana Grows Flourish
Illegal THC on every corner, Illegal grow ops in plain sight, Yet the DEA continues to block MMJ BioPharma Cultivation's FDA sanctioned application to produce pharmaceutical-grade cannabis pending since 2018. Read More
Press Release
Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
New subsidiary, Cynaptec Pharmaceuticals, established to hold global rights to Conjugated Psilocin™ $6 million investment in Cynaptec Pharmaceuticals secured to advance research and early-stage clinical trials for chronic cluster headaches and addiction Option for an additional $20 million investment in Cynaptec Pharmaceuticals to support Phase 3 clinical development Read More
Press Release
Blood Pressure 911 Under Review: The Most-Trusted Premium High Blood Pressure Support Formula on the Market
Explore the natural formula behind Blood Pressure 911-PhytAge Laboratories' most trusted supplement for promoting heart health, improving circulation, and supporting healthy blood pressure levels in 2025. Read More
Press Release
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024 Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024 EBITDA loss improved 59% in Q4 2025 compared to Q4 2024, and 17% in FY 2025 compared to FY 2024 Read More
Press Release
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25
Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and Semiconductors Key VELDONA® Human Clinical Studies Secure Taiwan Regulatory Greenlight, Accelerating Development Read More
Press Release
Digital Health Innovator Quilt Health Secures $6m Seed Funding and Announces Partnership With NASCC to Revolutionize Trial and Treatment Access for Complex Conditions
Quilt Health expands its mission to streamline clinical trial recruitment, enhance patient access to therapies and strengthen provider networks for sickle cell disease Read More
Press Release
Desert Oasis Healthcare Named "Large Business of the Year" by Greater Coachella Valley Chamber of Commerce
Desert Oasis Healthcare has been named Large Business of the Year by the Greater Coachella Valley Chamber of Commerce, recognizing the organization’s exceptional leadership, innovation, and unwavering commitment to the health and well-being of the communities it serves. Read More
Press Release
Black Book Research Reveals Enhanced 2025 RCM KPI Framework to Navigate Evolving Healthcare Financial Landscape at HFMA Annual Conference
Innovative New Metrics Enable Precise Vendor Assessment, Reflecting AI Adoption, Strategic Outsourcing, and Financial Stability Amid Regulatory and Economic Shifts Read More
Press Release
Gruber Plastic Surgery Explores How Millennials and Gen Z are Redefining Plastic Surgery With The Natural Look
Younger People are Leading a Cultural Shift Toward Small, Natural-Looking Changes, Such as Baby Botox and Mini Facelifts, and Gruber Plastic Surgery is Ready to Meet the Demand Read More
Press Release
Drs. Lee Harrison and Alex Sundermann Join Next Gen Diagnostics Advisory Team to Advance Hospital-Based Infection Prevention
National Leaders in Hospital Genomic Surveillance Join in Key Advisory Roles as NGD Prepares to Deploy Real-Time Sequencing-Based Detection of Transmission in Hospitals Read More
Press Release
Black Book Research to Announce Top-Ranked 2025 Revenue Cycle Management Vendors at HFMA Annual Meeting, Based on Innovative KPI Framework
Comprehensive Rankings Leveraging Innovative KPIs Including AI Integration, Outsourcing Capabilities and Financial Resilience to Provide the Definitive Methodology for True Client Satisfaction in RCM Read More
Press Release
DEA Marijuana “Do-Nothing” Team Rewarded with Dubai Trips While MS and HD Patients Waited
"The era of rogue DEA regulators must end," said Duane Boise. "If DEA administrator nominee wants to restore credibility, he must start by naming and removing the Biden-era ‘Do-Nothing' team." Read More
Press Release
DASI Simulations Closes Third Funding Round of $5 Million; Finalizes 11 Commercial Agreements for Its AI-Powered Predictive Modeling Products for Structural Heart Care
Company expands sales force, engineering talent, patent portfolio, and implements 24/7 customer service amidst surging demand for AI-powered structural heart solutions. Read More
Press Release
I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare's Top Negotiated Drugs
Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that exposes flaws in the U.S. patent system Read More
Press Release
Health Plan Executives at AHIP 2025 Align Strongly on Value-Based Reimbursement Optimization as Top IT Priority, Black Book Survey Finds
VBRO technologies emerge as essential investments for payers navigating CMS and state-driven payment reforms, according to 849 executives polled pre-AHIP 2025 Read More
Press Release
DEA Delays MMJ Cannabis Research While Allowing Texas Ibogaine Studies Without Obstruction: The Tale of Two Schedule I Substances
Two Schedule I drugs. Two research tracks. One DEA double standard. MMJ BioPharma Cultivation's FDA sanctioned cannabis research has been stonewalled for seven years. Meanwhile, Texas launches state-funded ibogaine trials with full political support and zero DEA obstruction. Is federal drug policy about science or selective enforcement? Read More
Press Release
Healthletic Introduces Breakthrough Natural Formula for Cardiovascular Health and Vitality
Healthletic Launches a Science-Backed Natural Supplement for Heart Health and Daily Energy, Tapping Into 2025's Wellness Trends with Clinically Studied Ingredients and Transparent Formulation Standards Read More
Press Release
Nerve Fresh Gains Attention as Natural Neuropathy Relief Supplement With Science-Backed Herbal Formula
Dr. James Haleford's science-backed nerve support formula blends five natural botanicals-including prickly pear and passionflower-to combat inflammation, restore sensation, and reduce nerve pain for those suffering from neuropathy in 2025. Read More
Press Release
Inovalon ONE(R), Quality Spectrum(R), Converged Risk(R), and Converged Quality(R) Named #1 by Health Plan and Managed Care Clients for Fifth Consecutive Year - Black Book Research
Sweeping Q1-Q2 2025 survey of nearly 12,000 managed care IT users nationwide ranks top vendors across multiple categories; Inovalon secures top honors again. Read More
Press Release
